CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic `window of opportunity'
Crossref DOI link: https://doi.org/10.1186/s13075-014-0434-z
Published Online: 2014-09-24
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Greisen, Stinne Ravn
Schelde, Karen Kræmmer
Rasmussen, Tue Kruse
Kragstrup, Tue Wenzel
Stengaard-Pedersen, Kristian
Hetland, Merete Lund
Hørslev-Petersen, Kim
Junker, Peter
Østergaard, Mikkel
Deleuran, Bent
Hvid, Malene
License valid from 2014-09-24